摘要 |
An implantation device for use in the in-vivo destruction of thoracic duct lymphocytes has in adjacent but separate relationship a passage through which lymph to be treated can flow and an irradiation source capable of destroying lymphocytes. The irradiation source may be either a beta emitting radio isotope or an ultraviolet light source. A cannula device for diverting untreated lymph from, and returning treated lymph to, the thoracic duct is provided for communication with the treatment device. |